美国食品和药物管理局接受Genentech的申请,扩大Gazyva治疗狼. FDA accepts Genentech's application to expand Gazyva for lupus treatment.

美国食品和药物管理局已接受Genentech的申请,扩大Gazyva用于治疗系统性红斑狼 (最常见的一种形式). The FDA has accepted Genentech's application to expand the use of Gazyva to treat systemic lupus erythematosus, the most common form of lupus. 关于批准的决定预计将于2026年12月前作出. A decision on the approval is expected by December 2026.